1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
124.78 3.10 (2.55%)
277.4K
XNAS Volume

XNAS 26 Sep, 2025 2:40 PM (EDT)

Watchlist

Portfolio

Alert

Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 21 analysts

Repligen Corp. has a share price target of US$ 181, revenue growth forecast of 14.5%, and profit growth estimate of 299.7% for FY25, based on top 21 analyst calls.